Pharmacotherapy of hepatocellular carcinoma

By Perry John F   Strasser Simone I   George Jacob   Farrell Geoffrey C   McCaughan Geoffrey W  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2175-2185

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma

By Lin Chih-Lin   Kao Jia-Horng  

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 441-443

Future Medicine

Access to resources Recommend Favorite

Ademetionine 1,4 Butanedisulphonate vs Traditional Chinese Medicine for the Treatment of Hepatocellular Jaundice Complicating Chronic Viral Hepatitis

By Bao-en W.  

Clinical Drug Investigation, Vol. 21, Iss. 11, 2001-11 ,pp. : 765-773

Adis International

Access to resources Recommend Favorite

Current pharmacotherapy for the treatment of chronic hepatitis B

By Lagget M   Rizzetto M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1821-1827

Informa Healthcare

Access to resources Recommend Favorite

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

By Kim W. Ray   Loomba Rohit   Berg Thomas   Aguilar Schall Raul E.   Yee Leland J.   Dinh Phillip V.   Flaherty John F.   Martins Eduardo B.   Therneau Terry M.   Jacobson Ira   Fung Scott   Gurel Selim   Buti Maria   Marcellin Patrick  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3631-3638

Blackwell Publishing

Access to resources Recommend Favorite